Us Bancorp \De\ Insmed Inc Transaction History

Us Bancorp \De\

$75.6 Billion
Q4 2024

A detailed history of Us Bancorp \De\ transactions in Insmed Inc stock. As of the latest transaction made, Us Bancorp \De\ holds 9,533 shares of INSM stock, worth $762,163. This represents 0.0% of its overall portfolio holdings.

Number of Shares

9,533

Previous 7,932 20.18%

Holding current value

$762,163

Previous $579,000 13.64%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 05, 2025	BUY	$66.29 - $76.63 $106,130 - $122,684	1,601 Added 20.18%	9,533 $658,000
Q3 2024 Oct 28, 2024	BUY	$62.0 - $79.01 $175,088 - $223,124	2,824 Added 55.29%	7,932 $579,000
Q2 2024 Aug 06, 2024	BUY	$22.0 - $69.71 $10,142 - $32,136	461 Added 9.92%	5,108 $342,000
Q1 2024 May 07, 2024	BUY	$25.72 - $29.94 $5,941 - $6,916	231 Added 5.23%	4,647 $126,000
Q4 2023 Feb 09, 2024	BUY	$23.42 - $31.74 $98,879 - $134,006	4,222 Added 2176.29%	4,416 $136,000
Q3 2023 Nov 03, 2023	SELL	$19.86 - $26.93 $6,593 - $8,940	-332 Reduced 63.12%	194 $4,000
Q2 2023 Aug 09, 2023	BUY	$16.44 - $21.1 $5,047 - $6,477	307 Added 140.18%	526 $11,000
Q1 2023 May 09, 2023	BUY	$16.26 - $21.73 $3,560 - $4,758	219 New	219 $3,000
Q3 2022 Oct 27, 2022	BUY	$20.88 - $28.21 $334 - $451	16 New	16 $0
Q2 2022 Aug 01, 2022	SELL	$17.07 - $25.71 $11,027 - $16,608	-646 Closed	0 $0
Q1 2022 May 11, 2022	SELL	$20.42 - $28.13 $22,523 - $31,027	-1,103 Reduced 63.06%	646 $15,000
Q4 2021 Feb 11, 2022	SELL	$25.89 - $33.45 $21,229 - $27,429	-820 Reduced 31.92%	1,749 $47,000
Q3 2021 Nov 10, 2021	BUY	$22.46 - $29.47 $45,369 - $59,529	2,020 Added 367.94%	2,569 $70,000
Q2 2021 Aug 05, 2021	BUY	$24.17 - $36.01 $507 - $756	21 Added 3.98%	549 $15,000
Q1 2021 Apr 28, 2021	BUY	$32.28 - $44.3 $2,162 - $2,968	67 Added 14.53%	528 $18,000
Q3 2020 Nov 10, 2020	BUY	$26.0 - $34.5 $1,430 - $1,897	55 Added 13.55%	461 $15,000
Q2 2020 Aug 07, 2020	BUY	$14.11 - $29.42 $5,728 - $11,944	406 New	406 $11,000
Q2 2019 Aug 13, 2019	SELL	$23.0 - $32.19 $4,600 - $6,438	-200 Closed	0 $0
Q1 2019 May 08, 2019	SELL	$13.91 - $31.15 $3,922 - $8,784	-282 Reduced 58.51%	200 $6,000
Q3 2018 Nov 01, 2018	SELL	$18.95 - $28.08 $2,728 - $4,043	-144 Reduced 23.0%	482 $10,000
Q2 2018 Aug 08, 2018	SELL	$20.0 - $29.72 $1,100 - $1,634	-55 Reduced 8.08%	626 $15,000
Q1 2018 May 08, 2018	SELL	$21.69 - $32.99 $15,877 - $24,148	-732 Reduced 51.8%	681 $15,000
Q4 2017 Feb 02, 2018	BUY	$26.43 - $31.78 $19,135 - $23,008	724 Added 105.08%	1,413 $44,000
Q3 2017 Nov 13, 2017	BUY	$11.61 - $31.21 $7,999 - $21,503	689	689 $22,000

Others Institutions Holding INSM

# of Institutions

481

Shares Held

182M

Call Options Held

2.27M

Put Options Held

3.32M

View Full List

About INSMED Inc

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $10.8B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

More about INSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.

Account